Royalty Pharma plc Class A Ordinary Shares RPRX
$57.99
-0.51%
at last close
Financials (TTM)
- Revenue
- $2.54 billion
- Net Income
- $1.35 billion
- Net Margin
- 53.23%
- Return on Equity
- 13.79%
- Debt-to-Equity
- 0.92
- P/E Ratio
- 30.85
- Price / Book
- 2.65
- Price / Sales
- 10.23
Over the trailing twelve months, Royalty Pharma plc Class A Ordinary Shares generated revenue of $2.54 billion and net income of $1.35 billion, a net margin of 53.23%.
At the last closing price of $57.99, RPRX trades at 30.85 times trailing earnings and 10.23 times sales, with a market capitalization of $25.96 billion.
Key Stats
- Last Close
- $57.99
- Market Cap
- $25.96 billion
- 52-Week Range
- $34.08 – $64.38
- Average Volume
- 2.90 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.